Fexofenadine/pseudoephedrine
Combination of
FexofenadineAntihistamine
PseudoephedrineNasal decongestant
Clinical data
Trade namesAllegra-D
MedlinePlusa601053
License data
Pregnancy
category
  • AU: B2
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

Fexofenadine/pseudoephedrine, sold under the brand name Allegra-D among others, is a fixed-dose combination medication used for the treatment of nasal congestion and other symptoms of allergies[4] and the common cold.[2] It contains fexofenadine, as the hydrochloride, an antihistamine; and pseudoephedrine, as the hydrochloride, a nasal decongestant.[2]

In 2020, it was the 381st most commonly prescribed medication in the United States, with more than 300 thousand prescriptions.[5]

References

  1. ↑ "Allegra-D Product information". Health Canada. 25 April 2012. Retrieved 2 June 2022.
  2. 1 2 3 "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 3 December 2020. Retrieved 2 June 2022.
  3. ↑ "Allegra-D Allergy and Congestion- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release". DailyMed. 30 August 2021. Retrieved 2 June 2022.
  4. ↑ Mansfield LE (May 2006). "Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis". Expert Opinion on Pharmacotherapy. 7 (7): 941–51. doi:10.1517/14656566.7.7.941. PMID 16634716. S2CID 23165002.
  5. ↑ "Fexofenadine; Pseudoephedrine - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.